Atomoxetine in the Treatment of Adults with Subthreshold and/or Late Onset Attention‐Deficit Hyperactivity Disorder‐Not Otherwise Specified (ADHD‐NOS): A Prospective Open‐Label 6‐Week Study

The objective of this study was to evaluate the efficacy and tolerability of atomoxetine hydrochloride (ATX) in the treatment of adults with atypical manifestations of attention‐deficit hyperactivity disorder (ADHD) (not otherwise specified [NOS]). We hypothesized that treatment with ATX will be saf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CNS Neurosci Ther
Autors principals: Surman, Craig, Hammerness, Paul, Petty, Carter, Doyle, Robert, Chu, Nicole, Gebhard, Nitzah, Williams, Courtney, Biederman, Joseph
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493840/
https://ncbi.nlm.nih.gov/pubmed/20070786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2009.00124.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars